These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33095334)

  • 21. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra.
    Brenner M; Ruzicka T; Plewig G; Thomas P; Herzer P
    Br J Dermatol; 2009 Nov; 161(5):1199-201. PubMed ID: 19673875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secukinumab for PASS syndrome: A new choice for therapeutic challenge?
    Li M; Xiang H; Liang Y; Xue L; Zhou X; Yang L; Liu H; Yang M; Tang J; Li W
    Dermatol Ther; 2022 Jul; 35(7):e15507. PubMed ID: 35419914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hidradenitis suppurativa from the typical patient to the new clinical phenotypes.
    Hristakieva E; Manuelyan K; Gancheva T; Lavcheva R; Deliyska R
    Clin Dermatol; 2023; 41(5):584-591. PubMed ID: 37652191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninfectious genital ulcers.
    Kirshen C; Edwards L
    Semin Cutan Med Surg; 2015 Dec; 34(4):187-91. PubMed ID: 26650697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone.
    Staub J; Pfannschmidt N; Strohal R; Braun-Falco M; Lohse P; Goerdt S; Leverkus M
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2243-7. PubMed ID: 25352307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyoderma gangrenosum associated with hidradenitis suppurativa.
    Ah-Weng A; Langtry JA; Velangi S; Evans CD; Douglas WS
    Clin Exp Dermatol; 2005 Nov; 30(6):669-71. PubMed ID: 16197385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) syndrome: a single-institution case series with a focus on management.
    Yan A; Gallardo M; Savu A; Kaffenberger B
    Arch Dermatol Res; 2024 Jun; 316(7):397. PubMed ID: 38878169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent hidradenitis suppurativa, inflammatory acne, dissecting cellulitis of the scalp, and pyoderma gangrenosum in a 16-year-old boy.
    Koshelev MV; Garrison PA; Wright TS
    Pediatr Dermatol; 2014; 31(1):e20-1. PubMed ID: 24118007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome in end-stage renal disease successfully treated with adalimumab.
    De Wet J; Jordaan HF; Kannenberg SM; Tod B; Glanzmann B; Visser WI
    Dermatol Online J; 2017 Dec; 23(12):. PubMed ID: 29447652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) and polycystic ovary syndrome: Coincidentally or aetiologically connected?
    Zivanovic D; Masirevic I; Ruzicka T; Braun-Falco M; Nikolic M
    Australas J Dermatol; 2017 May; 58(2):e54-e59. PubMed ID: 26831949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful use of adalimumab to treat pyoderma gangrenosum, acne and suppurative hidradenitis (PASH syndrome) following colectomy in ulcerative colitis.
    Murphy B; Morrison G; Podmore P
    Int J Colorectal Dis; 2015 Aug; 30(8):1139-40. PubMed ID: 25564349
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
    Reddick CL; Singh MN; Chalmers RJ
    Dermatol Online J; 2010 Aug; 16(8):15. PubMed ID: 20804692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis).
    Marzano AV; Damiani G; Ceccherini I; Berti E; Gattorno M; Cugno M
    Br J Dermatol; 2017 Jun; 176(6):1588-1598. PubMed ID: 27943240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New treatment of pyoderma gangrenosum and hidradenitis suppurativa: A review.
    Yamanaka K
    J Dermatol; 2024 Feb; 51(2):172-179. PubMed ID: 38009911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyogenic Arthritis, Pyoderma Gangrenosum, Acne, Suppurative Hidradenitis (PA-PASH) Syndrome: An Atypical Presentation of a Rare Syndrome.
    Ursani MA; Appleyard J; Whiteru O
    Am J Case Rep; 2016 Aug; 17():587-91. PubMed ID: 27530224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure of Anakinra in a Case of Severe Hidradenitis Suppurativa.
    Russo V; Alikhan A
    J Drugs Dermatol; 2016 Jun; 15(6):772-4. PubMed ID: 27272089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adalimumab-induced pyoderma gangrenosum in a patient with hidradenitis suppurativa: A paradoxical reaction.
    Company-Quiroga J; Alique-García S; Martínez-Morán C; Khedaoui R; Romero-Maté A; Borbujo J
    Indian J Dermatol Venereol Leprol; 2019; 85(4):422-425. PubMed ID: 31115357
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term Remission of Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa Syndrome.
    Brokamp G; Bechtel M; Chung C
    Cutis; 2023 Jun; 111(6):E2-E6. PubMed ID: 37487120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PsAPASH: a rare and recent autoinflammatory syndrome associated with hidradenitis suppurativa.
    Gadelha RL; Paiva RDSR; Palitot EB; Costa JEFD
    An Bras Dermatol; 2020; 95(2):203-206. PubMed ID: 32063421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review.
    Hsiao JL; Antaya RJ; Berger T; Maurer T; Shinkai K; Leslie KS
    Arch Dermatol; 2010 Nov; 146(11):1265-70. PubMed ID: 21079064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.